EN
EN
中文
请输入要搜索的内容
Home
About Us
Who We Are
Management Team
Culture
Awards
Product Center
Healthcare
Bone Health
Medical Nutrition
Functional Skincare
Prescription Drugs
Gastroenterology
Critical Care
Metabolic Diseases
Innovative Drugs
Liver Disease
Oncology
Rare Diseases
Innovative Medical Devices
AI Radiosurgery Robot
Artificial Heart
Atrial Fibrillation
Innovation Layout
Production Operation
News
Investor Relations
Stock Data
Information Disclosure
Investor Interaction
General Meeting of Shareholders Vote
Sustainable Development
ESG Report
Social Responsibility Sustainability
Brand Citizenship
Career
Talent Philosophy
Talent Development
Compensation and Benefits
一级标题
一级标题
News
our news
News
-
our news
Qingdao Baheal Pharma's Phase III Project Officially Launches, Advanced Formulation Capacity Reaches a New Level
2025-05-16
Baheal Medical Expands Portfolio, Partners with Roche to Promote MabThera® Commercialization
2025-02-13
Baheal Medical Expands Platform, Partners with ZAP for Head and Neck Radiosurgery Robot
2024-11-26
Baheal Medical and Biostar Partner to Commercialize New Class 1 Oncology Drug
2024-11-14
Baheal Medical Wins Two Prestigious "Value" Awards in the Capital Market
2024-10-25
Shanghai Huanghai Pharma Wins 2024 Excellence in Quality Award
2024-09-25
«
1
2
3
4
5
6
»
返回顶部